WO2001068816A8 - Human histamine h3 gene variant-3 - Google Patents

Human histamine h3 gene variant-3

Info

Publication number
WO2001068816A8
WO2001068816A8 PCT/US2001/007714 US0107714W WO0168816A8 WO 2001068816 A8 WO2001068816 A8 WO 2001068816A8 US 0107714 W US0107714 W US 0107714W WO 0168816 A8 WO0168816 A8 WO 0168816A8
Authority
WO
WIPO (PCT)
Prior art keywords
gene variant
human histamine
polypeptides
polynucleotides
disclosed
Prior art date
Application number
PCT/US2001/007714
Other languages
French (fr)
Other versions
WO2001068816A1 (en
Inventor
Ping Tsui
Original Assignee
Smithkline Beecham Corp
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp, Smithkline Beecham Plc filed Critical Smithkline Beecham Corp
Publication of WO2001068816A1 publication Critical patent/WO2001068816A1/en
Publication of WO2001068816A8 publication Critical patent/WO2001068816A8/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
    • C07K14/723—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH receptor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Human histamine H3 gene variant-3 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing Human histamine H3 gene variant-3 polypeptides and polynucleotides in diagnostic assays.
PCT/US2001/007714 2000-03-13 2001-03-12 Human histamine h3 gene variant-3 WO2001068816A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US52531200A 2000-03-13 2000-03-13
US09/525,312 2000-03-13

Publications (2)

Publication Number Publication Date
WO2001068816A1 WO2001068816A1 (en) 2001-09-20
WO2001068816A8 true WO2001068816A8 (en) 2002-02-07

Family

ID=24092727

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/007714 WO2001068816A1 (en) 2000-03-13 2001-03-12 Human histamine h3 gene variant-3

Country Status (1)

Country Link
WO (1) WO2001068816A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000189171A (en) 1998-12-25 2000-07-11 Banyu Pharmaceut Co Ltd New guanosine triphosphate(gtp)-binding protein conjugated receptor protein
DE10125145A1 (en) 2001-05-22 2002-11-28 Gruenenthal Gmbh New C-furanyl- or C-thienyl-methylamine derivatives, useful e.g. for treating arrhythmia, emesis, inflammation, cardiovascular or neurodegenerative disease, asthma, glaucoma or especially pain
AU2002354016A1 (en) * 2001-11-13 2003-05-26 Merck And Co. Inc. Histamine receptor h3 polynucleotides
AU2003227358A1 (en) 2002-04-24 2003-11-10 Banyu Pharmaceutical Co., Ltd. Histamine receptor h3 ordinary activity mutant and utilization thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9503866D0 (en) * 1995-01-30 1995-04-19 Univ Sheffield

Also Published As

Publication number Publication date
WO2001068816A1 (en) 2001-09-20

Similar Documents

Publication Publication Date Title
EP1001023A3 (en) Frizzled-4, a putative Wnt-receptor
EP0939124A3 (en) MGBP1 sequences
WO2002059315A3 (en) Human nucleic acids and polypeptides and methods of use thereof
WO1999035266A3 (en) Human urotensin ii
WO2001068816A8 (en) Human histamine h3 gene variant-3
WO2001083744A3 (en) Natrium-calcium exchanger protein
EP0885959A3 (en) Human Wnt-5b protein
WO2001004141A3 (en) Seripancrin
WO2001032864A3 (en) Gpcr-kd5 polypeptides and dna sequences thereof
WO2001068703A8 (en) Human histamine h3 gene variant-2
WO2002008253A3 (en) A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
WO2001085921A3 (en) Human serine-threonine kinase-4
EP0887416A3 (en) Human AFC1
WO2001083768A3 (en) Serine-threonine kinase
WO2001072963A3 (en) Novel human uridine kinase
EP0890646A3 (en) HE2NW40 Serine Protease
EP0887415A3 (en) Human RCE1
WO2002014355A3 (en) Novel mitogen activated kinase
WO2000053628A3 (en) Genes encoding human potassium channel proteins
WO2001083771A3 (en) Human phospholipase c delta 5
WO2001055428A3 (en) Mprot45 metalloprotease
WO2001085954A3 (en) Serine-threonine kinase-3
WO1999038885A3 (en) Sbsemvl polypeptides, being members of the semaphorin protein family, and polynucleotides encoding the same
WO2001062779A3 (en) New transcription factor carp-2
EP0882791A3 (en) WNT-11 polypeptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): JP

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: C1

Designated state(s): GB JP

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 38/2001 UNDER (81) ADD "GB"; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

NENP Non-entry into the national phase in:

Ref country code: JP